Cyclacel Pharmaceuticals Stock Options Expiring on 16th of August
| CYCC Stock | USD 2.64 0.62 30.69% |
Cyclacel Pharmaceuticals' latest option contracts expiring on 2024-08-16 are carrying combined implied volatility of 0.0 with a put-to-call open interest ratio of 0.0 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-08-16. The current put volume is at 0, with calls trading at the volume of 0. This yields a 0.0 put-to-call volume ratio. The Cyclacel Pharmaceuticals option chain provides detailed quote and price information for the current Cyclacel Pharmaceuticals option contracts. It shows all of Cyclacel Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.
The chart above shows Cyclacel Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Cyclacel Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Cyclacel Pharmaceuticals' option, there is no secondary market available for investors to trade.
Cyclacel Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Cyclacel Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Cyclacel stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Cyclacel Pharmaceuticals' stock price goes up or down, the stock options follow.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclacel Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. Please note that buying 'in-the-money' options on Cyclacel Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Cyclacel Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Cyclacel Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Cyclacel Stock moves the wrong way.
At present, Cyclacel Pharmaceuticals' Sale Purchase Of Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation To Revenue is expected to grow to 3.31, whereas Total Stockholder Equity is forecasted to decline to about 576.6 K. Cyclacel Current Options Market Mood
Cyclacel Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Cyclacel Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most options investors, including buyers and sellers of Cyclacel Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Cyclacel Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Cyclacel Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Cyclacel contract
Base on the Rule 16, the options market is currently suggesting that Cyclacel Pharmaceuticals will have an average daily up or down price movement of about 0.0% per day over the life of the 2024-08-16 option contract. With Cyclacel Pharmaceuticals trading at USD 2.64, that is roughly USD 0.0. If you think that the market is fully incorporating Cyclacel Pharmaceuticals' daily price movement you should consider buying Cyclacel Pharmaceuticals options at the current volatility level of 0.0%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Cyclacel |
Cyclacel Pharmaceuticals Option Chain
When Cyclacel Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Cyclacel Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Cyclacel Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Cyclacel. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Cyclacel. It also shows strike prices and maturity days for a Cyclacel Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-08-16 CALL at $2.5 | 0.3025 | 0.4425 | 0 | 2024-08-16 | 0.0 - 5.0 | 0.05 | In |
Cyclacel Pharmaceuticals Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Cyclacel Pharmaceuticals Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Cyclacel Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cyclacel Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Already Invested in Cyclacel Pharmaceuticals?
The danger of trading Cyclacel Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cyclacel Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cyclacel Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cyclacel Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Cyclacel Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cyclacel Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cyclacel Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cyclacel Pharmaceuticals Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cyclacel Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For information on how to trade Cyclacel Stock refer to our How to Trade Cyclacel Stock guide.Note that the Cyclacel Pharmaceuticals information on this page should be used as a complementary analysis to other Cyclacel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Cyclacel Stock analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Cyclacel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cyclacel Pharmaceuticals. If investors know Cyclacel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cyclacel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (22.02) | Revenue Per Share 0.465 | Return On Assets (1.00) | Return On Equity (4.96) |
The market value of Cyclacel Pharmaceuticals is measured differently than its book value, which is the value of Cyclacel that is recorded on the company's balance sheet. Investors also form their own opinion of Cyclacel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cyclacel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cyclacel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cyclacel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cyclacel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cyclacel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cyclacel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.